5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
about
The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotypeEnvironmental immune disruptors, inflammation and cancer riskPhospholipid remodeling and eicosanoid signaling in colon cancer cellsMammalian lipoxygenases and their biological relevanceAntagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancerROS-mediated autophagy induced by dysregulation of lipid metabolism plays a protective role in colorectal cancer cells treated with gambogic acid.The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length CounterpartErlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessA transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation.Serum 5-LOX: a progressive protein marker for breast cancer and new approach for therapeutic target.The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway.Pleiotropic Role of Puupehenones in Biomedical Research.Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.Antioxidant activities of curcumin in allergic rhinitis.Cytoplasmic 5-Lipoxygenase Staining Is a Highly Sensitive Marker of Human Tumors of the Choroid Plexus.Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
P2860
Q26999358-AFA9F473-4E4A-4375-B0C2-8E745286BB81Q28080870-3B1C419D-CC6C-473A-A2C7-A8E2493B0886Q28086810-6AB1C006-1B3A-41F3-BF4C-F6B4909DCD3BQ28249730-1CCA47B6-E6F0-4906-BE85-FEFA9927C3BFQ30360857-BFFA0BA4-778A-431B-AC1F-3483E5D90C9DQ33583930-06423C12-CA09-4EDA-9ADE-1C949D2CB35BQ35691073-C6B9BF5F-D5D7-469C-B100-4B70A4862CBDQ36234132-F1168A3B-E4B5-44FC-95BE-E16859E2610CQ36929682-5D1A2183-D6D8-4748-8B81-9A10DC45C2F3Q37400156-63467FD8-B89F-4A5C-9E4F-00989E344180Q38757063-084FADD6-BFE1-4C38-B34D-EE7CC8D073D0Q38785505-C4486589-3937-4A0A-B521-A06AC818816DQ38891976-DC28C877-0B85-47CB-BF4F-6596E27EC431Q38908564-A465B42F-BD3B-4E64-928F-4A2236D45248Q44218580-D7270B81-B161-4DB6-8011-521C07C8FE33Q47280362-804CF1DD-10E8-4B4C-8B73-7B9CCEDBBCADQ50437959-85D8263C-CA78-4CA5-BEDC-9A2555230B41Q50901671-8CFB1B63-01EA-4504-857D-FB549947A258Q52151918-A8BA5167-099B-45AF-85F2-E6084441C558Q58558257-3D41A971-EFFD-4D0A-9AD9-A00834F7FE1A
P2860
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@ast
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@en
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@nl
type
label
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@ast
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@en
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@nl
prefLabel
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@ast
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@en
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@nl
P2860
P3181
P356
P1476
5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy
@en
P2093
Anisur Rahman Khuda-Bukhsh
P2860
P304
P3181
P356
10.1093/ABBS/GMT064
P407
P577
2013-09-01T00:00:00Z